US2020323890A1PendingUtilityA1
Oral rehydration composition with oligosaccharides
Est. expiryDec 20, 2033(~7.4 yrs left)· nominal 20-yr term from priority
A61K 35/741A61K 33/30A61K 33/14A23L 33/21A61K 31/702A23L 2/52A61K 33/00A23V 2002/00A23L 2/39A23L 33/10A61K 31/717A61K 2035/115A61K 9/0095A23L 29/30A23L 33/125A23L 33/16A61K 31/194A61K 31/7004
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The general inventive concepts are directed to compositions and methods for the prevention and treatment of dehydration. Provided herein are nutritional compositions including oral rehydration compositions. Certain embodiments of the nutritional compositions have an acidic pH, and comprise a digestible carbohydrate, sodium, citrate, and an oligosaccharide selected from a fucosylated oligosaccharide and an N-acetylated oligosaccharide.
Claims
exact text as granted — not AI-modified1 - 42 . (canceled)
43 . A nutritional composition comprising:
a human milk oligosaccharide selected from the group consisting of a fucosylated oligosaccharide, an N-acetylated oligosaccharide, and combinations thereof in an amount of 10 mg to 5000 mg per liter of the nutritional composition; a digestible carbohydrate in addition to the human milk oligosaccharide in an amount of from 10 mM to 150 mM of carbohydrate of the nutritional composition; and sodium in an amount of 10 mEq to 100 mEq of sodium per liter of the nutritional composition; and wherein the nutritional composition is shelf stable for at least three months.
44 . The nutritional composition of claim 43 , wherein the human milk oligosaccharide is selected from 2′-fucosyllactose and lacto-N-neotetraose.
45 . The nutritional composition of claim 44 , wherein the human milk oligosaccharide is 2′-fucosyllactose.
46 . The nutritional composition of claim 45 , wherein the 2′-fucosyllactose is present in an amount of 20 mg to 4000 mg per liter of the nutritional composition.
47 . The nutritional composition of claim 45 further comprising at least one neutral human milk oligosaccharide.
48 . The nutritional composition of claim 43 wherein the nutritional composition does not comprise a sialylated oligosaccharide.
49 . The nutritional composition of claim 43 , wherein the nutritional composition is shelf stable for at least six months.
50 . The nutritional composition of claim 45 further comprising galactooligosaccharides.
51 . The nutritional composition of claim 45 further comprising at least one of protein and fat.
52 . The nutritional composition of claim 45 , wherein the digestible carbohydrate is selected from the group consisting of dextrose, maltodextrin, starch, isomaltulose, sucromalt, rice syrup, and rice syrup solids.
53 . The nutritional composition of claim 45 , wherein the digestible carbohydrate is dextrose.
54 . The nutritional composition of claim 45 , wherein the sodium is selected from the group consisting of sodium chloride, sodium phosphate, sodium citrate, sodium carbonate, sodium bicarbonate, sodium hydroxide, sodium ascorbate and combinations thereof.
55 . The nutritional composition of claim 45 further comprising a probiotic.
56 . The nutritional composition of claim 45 further comprising chloride.
57 . The nutritional composition of claim 56 , wherein the chloride is selected from the group consisting of sodium chloride, potassium chloride, calcium chloride, magnesium chloride, and combinations thereof.
58 . The nutritional composition of claim 45 further comprising zinc.
59 . The nutritional composition of claim 58 , wherein the zinc is selected from the group consisting of zinc gluconate, zinc sulfate, zinc chloride, zinc citrate, zinc bicarbonate, zinc carbonate, zinc hydroxide, zinc lactate, zinc acetate, zinc fluoride, zinc bromide, zinc sulfonate, and combinations thereof.
60 . The nutritional composition of claim 45 further comprising citrate.
61 . The nutritional composition of claim 60 , wherein the citrate is selected from the group consisting of potassium citrate, sodium citrate, zinc citrate, and combinations thereof.
62 . An aqueous oral rehydration composition comprising:
a human milk oligosaccharide selected from the group consisting of a fucosylated oligosaccharide, an N-acetylated oligosaccharide, and combinations thereof in an amount of 10 mg to 5000 mg per liter of the nutritional composition; a digestible carbohydrate in addition to the human milk oligosaccharide in an amount of from 10 mM to 150 mM of carbohydrate of the nutritional composition; and sodium in an amount of 10 mEq to 100 mEq of sodium per liter of the nutritional composition; wherein the aqueous oral rehydration composition has a pH of about 2 to about 6.5 and is shelf stable for at least three months after heat sterilization.Join the waitlist — get patent alerts
Track US2020323890A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.